Overall rank by patents
#13,440
of 49,997 tracked assignees
USPTO PatentsView assignee record - 22 granted patents across 21 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21B (Fusion Reactors).
The verdict
According to USPTO PatentsView, General ranks #13,440 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 21 technology areas.
USPTO PatentsView assignee plate
Corpus R13440 · Foreign Corporation #13,440 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Galera Labs, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
General Fusion · this assignee
40 score
3D Lighting… · lowest
7 score
What this shows General's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
General Fusion Inc. is a focused PatentsView assignee: 21 CPC subclasses with 81.8% of grants classified under G21B (Fusion Reactors). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2019. By volume, General sits between Glaxosmithkline Consumer Healthcare (UK) IP Limited and Global Marketing Enterprise (GME) Ltd..
General Fusion Inc. shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Glaxosmithkline Consumer Healthcare (UK) IP Limited
22 patents
GPB Scientific, LLC
22 patents
GPSip, Inc.
22 patents
Galera Labs, LLC
22 patents
Genesis Advanced Technology Inc.
22 patents
Genesis Robotics and Motion Technologies Canada, ULC
22 patents
Gestamp Hardtech AB
22 patents
Global Marketing Enterprise (GME) Ltd.
22 patents
General Fusion Inc.
22 patents
What this shows General holds 22 patents at rank #13,443, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,443 in granted patent volume.
Other assignees with the most granted patents in General's primary technology class.
General's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 5 | 22.7% |
| 2017 | 2 | 9.1% |
| 2018 | 5 | 22.7% |
| 2019 | 1 | 4.5% |
| 2020 | 3 | 13.6% |
| 2021 | 3 | 13.6% |
| 2022 | 2 | 9.1% |
| 2023 | 1 | 4.5% |
Top 15 of 21 technology areas
Overall rank by patents
#13,440
of 49,997 tracked assignees
40.0 out of 100
What to do with this data
General Fusion Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.